These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27411421)

  • 1. A case of hyperkinetic movement disorder associated with LGI1 antibodies.
    Erer Özbek S; Yapıcı Z; Tüzün E; Giriş M; Duran S; Taşkapılıoğlu Ö; Okan M
    Turk J Pediatr; 2015; 57(5):514-7. PubMed ID: 27411421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
    Schimmel M; Frühwald MC; Bien CG
    Eur J Paediatr Neurol; 2018 Jan; 22(1):190-193. PubMed ID: 28919330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid.
    Zhang F; Zhou H; Yi Y; Li N; Liu M; Shen H; Guo Y; Wang J
    Neurol Sci; 2024 Sep; 45(9):4493-4500. PubMed ID: 38551680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.
    Shin YW; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Kim TJ; Lee KJ; Kim YS; Park KI; Jung KH; Lee SK; Chu K
    J Neuroimmunol; 2013 Dec; 265(1-2):75-81. PubMed ID: 24176648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of smoldering anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-associated limbic encephalitis with faciobrachial dystonic seizure].
    Nakaoku Y; Maki T; Kanazawa K; Matsumoto R; Fukuyama H; Takahashi R; Ikeda A
    Rinsho Shinkeigaku; 2013; 53(9):706-11. PubMed ID: 24097318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare case of limbic encephalitis with anti leucine-rich glioma inactivated-1 (LGI1) antibodies.
    Shen N; Ren H; Wu J; Feng J; Cui L; Fang S
    Neuro Endocrinol Lett; 2014; 35(2):95-7. PubMed ID: 24878970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
    Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
    Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal B-cell activation in LGI1 antibody encephalitis.
    Lehmann-Horn K; Irani SR; Wang S; Palanichamy A; Jahn S; Greenfield AL; Dandekar R; Lepennetier G; Michael S; Gelfand JM; Geschwind MD; Wilson MR; Zamvil SS; von Büdingen HC
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32029531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leucine-rich Glioma-inactivated Protein 1 Antibody-associated Encephalitis:Report of Two Cases].
    Zhao JJ; Yang YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):714-718. PubMed ID: 31699206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
    Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
    Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
    Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
    Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.
    Szots M; Marton A; Kover F; Kiss T; Berki T; Nagy F; Illes Z
    J Neurol Sci; 2014 Aug; 343(1-2):198-202. PubMed ID: 24928080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
    van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
    Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leucine-rich glioma inactivated-1 protein antibody associated limbic encephalitis: one case report].
    Zheng YM; Sun W; Wang ZX; Zhang W; Yuan Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):646-9. PubMed ID: 25131487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies.
    Messelmani M; Fekih-Mrissa N; Zaouali J; Mrissa R
    Ann Saudi Med; 2015; 35(1):76-9. PubMed ID: 26142944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
    Li JM; Ma XR; Peng T; Li JH; Lu H
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1947-1951. PubMed ID: 32629594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.